Leukemia Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. We publish a range of content types including original research articles, reviews, letters, correspondence and commen

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: Monthly


3966 €

Gold OA


Green OA

2474 €

Non OA




SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Aims and Scope

Oncology Cancer Leukemia Oncogenes Genomics

Best articles

A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation

View more

A method for identifying differentially expressed genes in rare populations of primary human hematopoietic cells

View more

A note on myeloperoxidation index and its correlation to the biomarker, urine trans, trans-muconic acid level, in the subjects occupationally exposed to benzene

View more

A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma

View more

ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia

View more

Acute lymphoblastic leukemia in a patient with congenital neutropenia without G-CSF-R and ELA2 mutations

View more

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

View more

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia

View more

Apoptosis-resistant phenotype of classical Hodgkin's lymphoma is not mediated by somatic mutations within genes encoding members of the death-inducing signaling complex (DISC)

View more

Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-a (TNF-a) in NB4 leukemic cells: specific involvement of TNF receptor type 1

View more

Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach

View more

Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia

View more

Bidirectional differentiation involving a cell with rearrangement of the MLL gene

View more

BRAF gene is not mutated in mismatch repair-proficient or -deficient plasma cell dyscrasias

View more

Cell Cycle Checkpoints and Cancer

View more

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical-biological situations

View more

Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonrandom acquisition of chromosomal changes

View more

Chronic graft-versus-host disease: where is promise for the future?

View more

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

View more

Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib

View more

Co-existence of pseudo-Chediak-Higashi anomaly and double minutes containing C-MYC oncogene in three patients with AML M2

View more

Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia

View more

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb

View more

Defective class II transactivator expression in a B lymphoma cell line

View more


No comments ... Be the first to comment!